CENIOS GmbH, founded in August 2021, is an innovative biotech company specializing in quantitative point-of-care testing (qPOCT) for precise measurement of analytes like antibiotics, toxins, and cytostatics.

Their patented method enables fast, reliable, and user-friendly absolute quantification, enhancing patient safety, environmental monitoring, and food quality. Using proprietary test strips and a compact reader, CENIOS provides accurate diagnostics for human and veterinary medicine, environmental analysis, and the food industry.